- Rite Aid's turnaround plan revolves around enhancing the in-store customer experience, which previous company executives and other retailers have already tried and failed.
- The income statement is plagued by unusual, non-recurring impairment and restructuring charges that cloud the picture of the company's performance.
- The free cash flow price multiple provides a reliable valuation metric that incorporates the risks and opportunities of the company's new ventures.
- Rite Aid is in a position to benefit from the rollout of the COVID vaccine in the first quarter of 2021.
For further details see:
Rite Aid Is Fighting Back Against Online Competition, But With The Wrong Tools